<unk> , sold under the brand name Nexlizet among others, is a fixed-dose combination medication used for the treatment of high cholesterol. It is a combination of<unk> <unk>  and ezetimibe. The most common side effects are hyperuricemia (high blood levels of uric<unk>  and constipation.<unk> <unk>  is an adenosine triphosphate-citrate lyase (ACL) inhibitor and ezetimibe is a cholesterol absorption inhibitor.<unk> <unk>  works by blocking an enzyme in the liver called adenosine triphosphate citrate lyase, which is involved in making cholesterol. Ezetimibe works by binding to a gut protein called 'Niemann-Pick C1 Like 1', preventing cholesterol from being absorbed into the blood from the gut. The combination was approved for medical use in the United States in February 2020, and in the European Union in March 2020.
Bempedoic acid/ezetimibe
Ezetimibe/simvastatin
Ezetimibe/atorvastatin
Ezetimibe/rosuvastatin
Fenofibrate/simvastatin
Fenofibrate/pravastatin
Dapagliflozin/saxagliptin/metformin
Empagliflozin/linagliptin/metformin